Research programme: molecular glue degrader therapeutics - Merck/Proxygen
Latest Information Update: 10 Jun 2022
At a glance
- Originator Proxygen
- Class Small molecules
- Mechanism of Action Proteolysis
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Unspecified